Bristol-Myers Squibb (BMY)
$66.68 0.66 (1.00%)
12:59 EST BMY Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 108.99B
PE Ratio 116.98
Volume (Avg. Vol.) 4.95M
Day's Range 65.54 - 66.86
52-Week Range 45.76 - 68.34
Dividend & Yield 1.60 (2.40%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
- From InvestorPlace
- From the Web
Pharmaceutical stocks have many benefits, particularly when their products are in demand. And in 2021, that seems likely to be the case.
By Alex Sirois
Pharmaceutical stocks can be a great investment in a unique niche of the market. The stocks on this list will be strong for a decade plus.
By Alex Sirois
2020 has taken the market capitalizations of many strong companies to lows. That means there are some great options for cheap stocks to buy in January.
Everyone is on the hunt for undervalued stocks. Keep in mind, even more highly valued stocks can be undervalued. Let's look at seven of them.
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.
These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election.
Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.
MyoKardia's major, $13.1 billon deal with fellow pharmaceutical company Bristol Myers Squibb sent MYOK stock soaring on Monday.
Alexandria Real Estate Equities is the largest landlord in the US for laboratories and related offices.
Bristol-Myers Squibb, Uber, Facebook, Micron and Twilio were our top stock trades for Friday. That said, let's look at the charts now.
Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.
BMY stock looks cheap here. Bristol-Myers is a defensive value with an attractive yield, cheap valuation, and plenty of potential upside.
These five healthcare stocks have low P/E ratios and ample yields, making them cheap and profitable options for investors.
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader